Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 3 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $28K 201 sh | Jan 14, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $15K 100 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $14K 100 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $14K 100 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $43K 300 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $29K 200 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 1 | Spector DavidDirector, Chairman & CEO |  PFSIPennyMac Financial Services, Inc.Open-market sale · 10b5-1 plan | SELL | $7,022 48 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 1 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. |  ANIPANI PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $42K 500 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 1 | Murry Stefan J.Chief Financial Officer |  AAOIAPPLIED OPTOELECTRONICS, INC.Open-market sale · 10b5-1 plan | SELL | $33K 934 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 0 | Lee Anthony PDirector |  RBLXRoblox CorpOpen-market sale · 10b5-1 plan | SELL | $40K 490 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 0 | Lee Anthony PDirector | RBLXRoblox Corp Open-market sale · 10b5-1 plan | SELL | $40K 490 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 42 | Fischer Gregory MichaelDirector |  SMTCSEMTECH CORPOpen-market sale | SELL | $78K 1,034 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 32 | Robinson Mark HaymondGeneral Counsel and Secretary |  GMEGameStop Corp.Open-market sale | SELL | $256K 12.2K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 31 | Britt Christopher RDirector, Chief Executive Officer |  CHYMChime Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $1.40M 50.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 28 | Cumello JosephSVP, General Mgr. Blue Planet |  CIENCIENA CORPOpen-market sale · 10b5-1 plan | SELL | $2.74M 11.9K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 28 | Houston AndrewDirector, Chief Executive Officer, 10% Owner |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $996K 36.2K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 27 | Benkowitz MichaelPRESIDENT AND COO |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $7.01M 14.6K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 27 | Benkowitz MichaelPRESIDENT AND COO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $3.78M 7,875 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 26 | Levy Adam ScottCFO and Secretary |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $346K 10.8K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 24 | Houston AndrewDirector, Chief Executive Officer, 10% Owner | DBXDROPBOX, INC. Open-market sale · 10b5-1 plan | SELL | $655K 23.8K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 23 | Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner |  IRMDIRADIMED CORPOpen-market sale | SELL | $476K 4,888 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 23 | Thygesen Allan C.Director, President and CEO |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $1.12M 16.2K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 23 | Vollero AndrewChief Financial Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $52K 200 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 22 | Vollero AndrewChief Financial Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $426K 1,636 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 22 | Vollero AndrewChief Financial Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $314K 1,200 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 21 | Caldwell Nick V.Chief Product Officer |  PTONPELOTON INTERACTIVE, INC.Open-market sale · 10b5-1 plan | SELL | $530K 75.8K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Grayson Blake JeffreyChief Financial Officer | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $455K 6,500 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Vashisht RijuSenior Vice President |  GGenpact LTDOpen-market sale · 10b5-1 plan | SELL | $747K 16.0K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 20 | Vollero AndrewChief Financial Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 100 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Urist MarshallEVP, Research & Investments |  RPRXRoyalty Pharma plcOpen-market sale · 10b5-1 plan | SELL | $816K 20.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Nakamura KatsufumiSVP, Chief Customer Officer |  ADIANALOG DEVICES INCOpen-market sale | SELL | $151K 500 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Thygesen Allan C.Director, President and CEO | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $686K 9,799 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Dewan SameerSenior Vice President | GGenpact LTD Open-market sale · 10b5-1 plan | SELL | $704K 15.1K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 19 | Ahn KennethPresident, Hagerty Marketplace |  HGTYHagerty, Inc.Open-market sale · 10b5-1 plan | SELL | $643K 50.0K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 19 | Taub RebeccaDirector |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $1.06M 2,044 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.03M 1,996 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Vollero AndrewChief Financial Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $194K 738 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 19 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.28M 2,432 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.27M 2,450 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Patel AnishCHIEF OPERATING OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.34M 48.1K sh | Jan 13, 2026 traded Jan 9, 2026 |